Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan 28:9:597-603.
doi: 10.2147/OTT.S97019. eCollection 2016.

Advances in dosimetry and biological predictors of radiation-induced esophagitis

Affiliations
Review

Advances in dosimetry and biological predictors of radiation-induced esophagitis

Yang Yu et al. Onco Targets Ther. .

Abstract

Objective: To summarize the research progress about the dosimetry and biological predictors of radiation-induced esophagitis.

Methods: We performed a systematic literature review addressing radiation esophagitis in the treatment of lung cancer published between January 2009 and May 2015 in the PubMed full-text database index systems.

Results: Twenty-eight eligible documents were included in the final analysis. Many clinical factors were related to the risk of radiation esophagitis, such as elder patients, concurrent chemoradiotherapy, and the intense radiotherapy regimen (hyperfractionated radiotherapy or stereotactic body radiotherapy). The parameters including Dmax, Dmean, V20, V30, V50, and V55 may be valuable in predicting the occurrence of radiation esophagitis in patients receiving concurrent chemoradiotherapy. Genetic variants in inflammation-related genes are also associated with radiation-induced toxicity.

Conclusion: Dosimetry and biological factors of radiation-induced esophagitis provide clinical information to decrease its occurrence and grade during radiotherapy. More prospective studies are warranted to confirm their prediction efficacy.

Keywords: esophagitis; lung cancer; predictors; radiation injuries.

PubMed Disclaimer

References

    1. Belderbos J, Heemsbergen W, Hoogeman M, Pengel K, Rossi M, Lebesque J. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol. 2005;75(2):157–164. - PubMed
    1. Choy H, LaPorte K, Knill-Selby E, Mohr P, Shyr Y. Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer. Semin Radiat Oncol. 1999;9(2 Suppl 1):S90–S96. - PubMed
    1. Takeda K, Nemoto K, Saito H, Ogawa Y, Takai Y, Yamada S. Predictive factors for acute esophageal toxicity in thoracic radiotherapy. Tohoku J Exp Med. 2006;208(4):299–306. - PubMed
    1. Kwint M, Uyterlinde W, Nijkamp J, et al. Acute esophagus toxicity in lung cancer patients after intensity modulated radiation therapy and concurrent chemotherapy. Int J Radiat Oncol Biol Phys. 2012;84(2):e223–e228. - PubMed
    1. Kuroda Y, Sekine I, Sumi M, et al. Acute radiation esophagitis caused by high-dose involved field radiotherapy with concurrent cisplatin and vinorelbine for stage III non-small cell lung cancer. Technol Cancer Res Treat. 2013;12(4):333–339. - PubMed

LinkOut - more resources